Back to search

Article

The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs

2021-03-23

Abstract excerpt

<h4>ABSTRACT</h4> In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs – agents active against both SARS-CoV-2 and other coronaviruses – would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3bfec31-5ad3-5545-8f18-798c92e844b2
DOI
10.1101/2021.03.23.436637
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugsDOI 10.1101/2021.03.23.436637
Select a neighboring publication to make it the new centre.